William Chase

Insider Reports History

Location
1 N. Waukegan Road, North Chicago, IL
Signature
/s/Donald Lang, as Attorney-in-Fact for William Chase
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Chase:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GRAIL, Inc. Director Common Stock 36.6K $2.76M $75.52 Oct 15, 2025 Direct
Intellia Therapeutics, Inc. Director Common Stock 135K $1.35M $10.03 Aug 20, 2025 Direct
Intellia Therapeutics, Inc. Director Stock Option (right to buy) 11.5K Jun 11, 2025 Direct

Insider Reports Filed by William Chase

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GRAL GRAIL, Inc. Oct 15, 2025 1 $20.8K 4 Oct 16, 2025 Director
NTLA Intellia Therapeutics, Inc. Aug 20, 2025 1 $1M 4 Aug 22, 2025 Director
GRAL GRAIL, Inc. Jul 15, 2025 1 $20.5K 4 Jul 17, 2025 Director
NTLA Intellia Therapeutics, Inc. Jun 11, 2025 2 $0 4 Jun 13, 2025 Director
GRAL GRAIL, Inc. May 29, 2025 1 $250K 4 May 30, 2025 Director
GRAL GRAIL, Inc. Apr 15, 2025 1 $20.3K 4 Apr 16, 2025 Director
GRAL GRAIL, Inc. Jan 15, 2025 1 $20.8K 4 Jan 16, 2025 Director
GRAL GRAIL, Inc. Oct 30, 2024 1 $2.86K 4 Nov 1, 2024 Director
GRAL GRAIL, Inc. Oct 15, 2024 1 $14.8K 4 Oct 17, 2024 Director
GRAL GRAIL, Inc. Jun 25, 2024 1 $0 4 Jun 27, 2024 Director
NTLA Intellia Therapeutics, Inc. Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
GRAL GRAIL, LLC Jun 11, 2024 0 $0 3 Jun 11, 2024 Director
NTLA Intellia Therapeutics, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
NTLA Intellia Therapeutics, Inc. Apr 14, 2023 2 $0 4 Apr 18, 2023 Director
NTLA Intellia Therapeutics, Inc. Apr 14, 2023 0 $0 3 Apr 18, 2023 Director